nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—vein—ovarian cancer	0.00981	0.158	CbGeAlD
Zuclopenthixol—DRD5—female reproductive system—ovarian cancer	0.00378	0.061	CbGeAlD
Zuclopenthixol—DRD5—female gonad—ovarian cancer	0.00344	0.0555	CbGeAlD
Zuclopenthixol—ADRA1A—epithelium—ovarian cancer	0.00234	0.0378	CbGeAlD
Zuclopenthixol—HRH1—myometrium—ovarian cancer	0.00231	0.0373	CbGeAlD
Zuclopenthixol—ADRA2A—myometrium—ovarian cancer	0.00227	0.0366	CbGeAlD
Zuclopenthixol—HTR2A—embryo—ovarian cancer	0.00186	0.0299	CbGeAlD
Zuclopenthixol—HRH1—epithelium—ovarian cancer	0.00181	0.0293	CbGeAlD
Zuclopenthixol—HRH1—uterine cervix—ovarian cancer	0.0018	0.029	CbGeAlD
Zuclopenthixol—ADRA2A—uterine cervix—ovarian cancer	0.00177	0.0285	CbGeAlD
Zuclopenthixol—HRH1—decidua—ovarian cancer	0.00171	0.0276	CbGeAlD
Zuclopenthixol—ADRA2A—decidua—ovarian cancer	0.00168	0.0271	CbGeAlD
Zuclopenthixol—HRH1—endometrium—ovarian cancer	0.00163	0.0262	CbGeAlD
Zuclopenthixol—ADRA2A—endometrium—ovarian cancer	0.0016	0.0258	CbGeAlD
Zuclopenthixol—HTR2A—epithelium—ovarian cancer	0.00151	0.0244	CbGeAlD
Zuclopenthixol—ADRA2A—gonad—ovarian cancer	0.00148	0.0239	CbGeAlD
Zuclopenthixol—Flupentixol—ABCB1—ovarian cancer	0.00148	0.175	CrCbGaD
Zuclopenthixol—ADRA2A—uterus—ovarian cancer	0.00147	0.0237	CbGeAlD
Zuclopenthixol—Clozapine—CYP1B1—ovarian cancer	0.00144	0.17	CrCbGaD
Zuclopenthixol—DRD2—testis—ovarian cancer	0.00138	0.0222	CbGeAlD
Zuclopenthixol—HRH1—female reproductive system—ovarian cancer	0.00135	0.0217	CbGeAlD
Zuclopenthixol—ADRA2A—female reproductive system—ovarian cancer	0.00132	0.0213	CbGeAlD
Zuclopenthixol—HTR2A—gonad—ovarian cancer	0.00126	0.0203	CbGeAlD
Zuclopenthixol—HRH1—female gonad—ovarian cancer	0.00123	0.0198	CbGeAlD
Zuclopenthixol—HRH1—vagina—ovarian cancer	0.00122	0.0197	CbGeAlD
Zuclopenthixol—ADRA2A—female gonad—ovarian cancer	0.0012	0.0194	CbGeAlD
Zuclopenthixol—ADRA2A—vagina—ovarian cancer	0.0012	0.0193	CbGeAlD
Zuclopenthixol—HTR2A—female reproductive system—ovarian cancer	0.00113	0.0182	CbGeAlD
Zuclopenthixol—HRH1—testis—ovarian cancer	0.00109	0.0175	CbGeAlD
Zuclopenthixol—ADRA2A—testis—ovarian cancer	0.00107	0.0172	CbGeAlD
Zuclopenthixol—Dry mouth—Paclitaxel—ovarian cancer	0.00106	0.00114	CcSEcCtD
Zuclopenthixol—Diarrhoea—Vinorelbine—ovarian cancer	0.00106	0.00114	CcSEcCtD
Zuclopenthixol—Ataxia—Doxorubicin—ovarian cancer	0.00105	0.00113	CcSEcCtD
Zuclopenthixol—Nausea—Melphalan—ovarian cancer	0.00105	0.00113	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00104	0.00112	CcSEcCtD
Zuclopenthixol—Eosinophilia—Epirubicin—ovarian cancer	0.00104	0.00112	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00104	0.00111	CcSEcCtD
Zuclopenthixol—Shock—Paclitaxel—ovarian cancer	0.00103	0.0011	CcSEcCtD
Zuclopenthixol—CYP2D6—female reproductive system—ovarian cancer	0.00102	0.0165	CbGeAlD
Zuclopenthixol—Dizziness—Vinorelbine—ovarian cancer	0.00102	0.0011	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Paclitaxel—ovarian cancer	0.00102	0.0011	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00102	0.0011	CcSEcCtD
Zuclopenthixol—HTR2A—vagina—ovarian cancer	0.00102	0.0164	CbGeAlD
Zuclopenthixol—Tachycardia—Paclitaxel—ovarian cancer	0.00102	0.00109	CcSEcCtD
Zuclopenthixol—Breast disorder—Doxorubicin—ovarian cancer	0.00101	0.00109	CcSEcCtD
Zuclopenthixol—Skin disorder—Paclitaxel—ovarian cancer	0.00101	0.00109	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00101	0.00108	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.001	0.00108	CcSEcCtD
Zuclopenthixol—Domperidone—ABCB1—ovarian cancer	0.000995	0.118	CrCbGaD
Zuclopenthixol—Pancytopenia—Epirubicin—ovarian cancer	0.000995	0.00107	CcSEcCtD
Zuclopenthixol—Anorexia—Paclitaxel—ovarian cancer	0.000993	0.00107	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000989	0.00106	CcSEcCtD
Zuclopenthixol—Vomiting—Vinorelbine—ovarian cancer	0.000985	0.00106	CcSEcCtD
Zuclopenthixol—Dysuria—Epirubicin—ovarian cancer	0.00098	0.00105	CcSEcCtD
Zuclopenthixol—Neutropenia—Epirubicin—ovarian cancer	0.00098	0.00105	CcSEcCtD
Zuclopenthixol—Rash—Vinorelbine—ovarian cancer	0.000977	0.00105	CcSEcCtD
Zuclopenthixol—Dermatitis—Vinorelbine—ovarian cancer	0.000976	0.00105	CcSEcCtD
Zuclopenthixol—Hypotension—Paclitaxel—ovarian cancer	0.000974	0.00105	CcSEcCtD
Zuclopenthixol—Headache—Vinorelbine—ovarian cancer	0.000971	0.00104	CcSEcCtD
Zuclopenthixol—Syncope—Docetaxel—ovarian cancer	0.000971	0.00104	CcSEcCtD
Zuclopenthixol—Leukopenia—Docetaxel—ovarian cancer	0.000969	0.00104	CcSEcCtD
Zuclopenthixol—Eosinophilia—Doxorubicin—ovarian cancer	0.00096	0.00103	CcSEcCtD
Zuclopenthixol—Palpitations—Docetaxel—ovarian cancer	0.000956	0.00103	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000956	0.00103	CcSEcCtD
Zuclopenthixol—Weight increased—Epirubicin—ovarian cancer	0.000954	0.00103	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Docetaxel—ovarian cancer	0.000951	0.00102	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00095	0.00102	CcSEcCtD
Zuclopenthixol—Weight decreased—Epirubicin—ovarian cancer	0.000948	0.00102	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000945	0.00102	CcSEcCtD
Zuclopenthixol—Insomnia—Paclitaxel—ovarian cancer	0.000943	0.00101	CcSEcCtD
Zuclopenthixol—Convulsion—Docetaxel—ovarian cancer	0.000938	0.00101	CcSEcCtD
Zuclopenthixol—Paraesthesia—Paclitaxel—ovarian cancer	0.000936	0.00101	CcSEcCtD
Zuclopenthixol—Hypertension—Docetaxel—ovarian cancer	0.000934	0.00101	CcSEcCtD
Zuclopenthixol—Drowsiness—Epirubicin—ovarian cancer	0.000934	0.001	CcSEcCtD
Zuclopenthixol—CYP2D6—female gonad—ovarian cancer	0.000933	0.015	CbGeAlD
Zuclopenthixol—Dyspnoea—Paclitaxel—ovarian cancer	0.000929	0.001	CcSEcCtD
Zuclopenthixol—Somnolence—Paclitaxel—ovarian cancer	0.000926	0.000997	CcSEcCtD
Zuclopenthixol—Myalgia—Docetaxel—ovarian cancer	0.000921	0.000991	CcSEcCtD
Zuclopenthixol—Pancytopenia—Doxorubicin—ovarian cancer	0.000921	0.00099	CcSEcCtD
Zuclopenthixol—Nausea—Vinorelbine—ovarian cancer	0.00092	0.00099	CcSEcCtD
Zuclopenthixol—Dyspepsia—Paclitaxel—ovarian cancer	0.000917	0.000987	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000915	0.000984	CcSEcCtD
Zuclopenthixol—Jaundice—Epirubicin—ovarian cancer	0.000911	0.00098	CcSEcCtD
Zuclopenthixol—HTR2A—testis—ovarian cancer	0.000908	0.0147	CbGeAlD
Zuclopenthixol—Dysuria—Doxorubicin—ovarian cancer	0.000907	0.000975	CcSEcCtD
Zuclopenthixol—Neutropenia—Doxorubicin—ovarian cancer	0.000907	0.000975	CcSEcCtD
Zuclopenthixol—Decreased appetite—Paclitaxel—ovarian cancer	0.000906	0.000975	CcSEcCtD
Zuclopenthixol—Dry mouth—Docetaxel—ovarian cancer	0.000901	0.000969	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.0009	0.000968	CcSEcCtD
Zuclopenthixol—Fatigue—Paclitaxel—ovarian cancer	0.000899	0.000967	CcSEcCtD
Zuclopenthixol—Sweating—Epirubicin—ovarian cancer	0.000896	0.000963	CcSEcCtD
Zuclopenthixol—Constipation—Paclitaxel—ovarian cancer	0.000891	0.000959	CcSEcCtD
Zuclopenthixol—Pain—Paclitaxel—ovarian cancer	0.000891	0.000959	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000885	0.000952	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000884	0.00095	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000883	0.00095	CcSEcCtD
Zuclopenthixol—Weight increased—Doxorubicin—ovarian cancer	0.000882	0.000949	CcSEcCtD
Zuclopenthixol—Weight decreased—Doxorubicin—ovarian cancer	0.000877	0.000944	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000875	0.000941	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Epirubicin—ovarian cancer	0.000872	0.000938	CcSEcCtD
Zuclopenthixol—Shock—Docetaxel—ovarian cancer	0.000869	0.000935	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Docetaxel—ovarian cancer	0.000866	0.000932	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000865	0.00093	CcSEcCtD
Zuclopenthixol—Drowsiness—Doxorubicin—ovarian cancer	0.000864	0.00093	CcSEcCtD
Zuclopenthixol—Tachycardia—Docetaxel—ovarian cancer	0.000862	0.000927	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000859	0.000924	CcSEcCtD
Zuclopenthixol—Skin disorder—Docetaxel—ovarian cancer	0.000858	0.000923	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000852	0.000917	CcSEcCtD
Zuclopenthixol—Jaundice—Doxorubicin—ovarian cancer	0.000843	0.000906	CcSEcCtD
Zuclopenthixol—Anorexia—Docetaxel—ovarian cancer	0.000842	0.000906	CcSEcCtD
Zuclopenthixol—Sweating—Doxorubicin—ovarian cancer	0.000829	0.000891	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000828	0.000891	CcSEcCtD
Zuclopenthixol—CYP2D6—testis—ovarian cancer	0.000827	0.0133	CbGeAlD
Zuclopenthixol—Nefazodone—ABCB1—ovarian cancer	0.000827	0.0976	CrCbGaD
Zuclopenthixol—Oedema peripheral—Epirubicin—ovarian cancer	0.000826	0.000889	CcSEcCtD
Zuclopenthixol—Hypotension—Docetaxel—ovarian cancer	0.000825	0.000888	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000824	0.000887	CcSEcCtD
Zuclopenthixol—Body temperature increased—Paclitaxel—ovarian cancer	0.000824	0.000886	CcSEcCtD
Zuclopenthixol—Abdominal pain—Paclitaxel—ovarian cancer	0.000824	0.000886	CcSEcCtD
Zuclopenthixol—Urethral disorder—Epirubicin—ovarian cancer	0.000822	0.000884	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000818	0.000879	CcSEcCtD
Zuclopenthixol—Visual impairment—Epirubicin—ovarian cancer	0.000808	0.000869	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000807	0.000868	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000805	0.000866	CcSEcCtD
Zuclopenthixol—Insomnia—Docetaxel—ovarian cancer	0.000799	0.000859	CcSEcCtD
Zuclopenthixol—Paraesthesia—Docetaxel—ovarian cancer	0.000793	0.000853	CcSEcCtD
Zuclopenthixol—HRH1—lymph node—ovarian cancer	0.000788	0.0127	CbGeAlD
Zuclopenthixol—Dyspnoea—Docetaxel—ovarian cancer	0.000788	0.000847	CcSEcCtD
Zuclopenthixol—Somnolence—Docetaxel—ovarian cancer	0.000785	0.000845	CcSEcCtD
Zuclopenthixol—Eye disorder—Epirubicin—ovarian cancer	0.000784	0.000843	CcSEcCtD
Zuclopenthixol—Tinnitus—Epirubicin—ovarian cancer	0.000782	0.000841	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Epirubicin—ovarian cancer	0.000778	0.000837	CcSEcCtD
Zuclopenthixol—Dyspepsia—Docetaxel—ovarian cancer	0.000778	0.000836	CcSEcCtD
Zuclopenthixol—ADRA2A—lymph node—ovarian cancer	0.000774	0.0125	CbGeAlD
Zuclopenthixol—Decreased appetite—Docetaxel—ovarian cancer	0.000768	0.000826	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000768	0.000826	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000766	0.000824	CcSEcCtD
Zuclopenthixol—Trazodone—ABCB1—ovarian cancer	0.000765	0.0903	CrCbGaD
Zuclopenthixol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000764	0.000822	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000763	0.00082	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000763	0.00082	CcSEcCtD
Zuclopenthixol—Fatigue—Docetaxel—ovarian cancer	0.000762	0.000819	CcSEcCtD
Zuclopenthixol—Angiopathy—Epirubicin—ovarian cancer	0.000761	0.000819	CcSEcCtD
Zuclopenthixol—Urethral disorder—Doxorubicin—ovarian cancer	0.000761	0.000818	CcSEcCtD
Zuclopenthixol—Immune system disorder—Epirubicin—ovarian cancer	0.000757	0.000815	CcSEcCtD
Zuclopenthixol—Pain—Docetaxel—ovarian cancer	0.000755	0.000813	CcSEcCtD
Zuclopenthixol—Constipation—Docetaxel—ovarian cancer	0.000755	0.000813	CcSEcCtD
Zuclopenthixol—Arrhythmia—Epirubicin—ovarian cancer	0.000749	0.000806	CcSEcCtD
Zuclopenthixol—Visual impairment—Doxorubicin—ovarian cancer	0.000748	0.000804	CcSEcCtD
Zuclopenthixol—Asthenia—Paclitaxel—ovarian cancer	0.000748	0.000804	CcSEcCtD
Zuclopenthixol—Pruritus—Paclitaxel—ovarian cancer	0.000737	0.000793	CcSEcCtD
Zuclopenthixol—Mental disorder—Epirubicin—ovarian cancer	0.000735	0.00079	CcSEcCtD
Zuclopenthixol—Malnutrition—Epirubicin—ovarian cancer	0.00073	0.000785	CcSEcCtD
Zuclopenthixol—Erythema—Epirubicin—ovarian cancer	0.00073	0.000785	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Docetaxel—ovarian cancer	0.000728	0.000783	CcSEcCtD
Zuclopenthixol—Eye disorder—Doxorubicin—ovarian cancer	0.000725	0.00078	CcSEcCtD
Zuclopenthixol—Tinnitus—Doxorubicin—ovarian cancer	0.000723	0.000778	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000722	0.000777	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Doxorubicin—ovarian cancer	0.00072	0.000775	CcSEcCtD
Zuclopenthixol—Flatulence—Epirubicin—ovarian cancer	0.000719	0.000774	CcSEcCtD
Zuclopenthixol—Tension—Epirubicin—ovarian cancer	0.000716	0.000771	CcSEcCtD
Zuclopenthixol—Diarrhoea—Paclitaxel—ovarian cancer	0.000713	0.000767	CcSEcCtD
Zuclopenthixol—Nervousness—Epirubicin—ovarian cancer	0.000709	0.000763	CcSEcCtD
Zuclopenthixol—Angiopathy—Doxorubicin—ovarian cancer	0.000704	0.000757	CcSEcCtD
Zuclopenthixol—Immune system disorder—Doxorubicin—ovarian cancer	0.000701	0.000754	CcSEcCtD
Zuclopenthixol—Abdominal pain—Docetaxel—ovarian cancer	0.000698	0.000751	CcSEcCtD
Zuclopenthixol—Body temperature increased—Docetaxel—ovarian cancer	0.000698	0.000751	CcSEcCtD
Zuclopenthixol—Arrhythmia—Doxorubicin—ovarian cancer	0.000693	0.000746	CcSEcCtD
Zuclopenthixol—Dizziness—Paclitaxel—ovarian cancer	0.000689	0.000741	CcSEcCtD
Zuclopenthixol—Vision blurred—Epirubicin—ovarian cancer	0.000688	0.00074	CcSEcCtD
Zuclopenthixol—Mental disorder—Doxorubicin—ovarian cancer	0.00068	0.000731	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000677	0.000729	CcSEcCtD
Zuclopenthixol—Malnutrition—Doxorubicin—ovarian cancer	0.000675	0.000727	CcSEcCtD
Zuclopenthixol—Erythema—Doxorubicin—ovarian cancer	0.000675	0.000727	CcSEcCtD
Zuclopenthixol—Agitation—Epirubicin—ovarian cancer	0.000671	0.000722	CcSEcCtD
Zuclopenthixol—Flatulence—Doxorubicin—ovarian cancer	0.000666	0.000716	CcSEcCtD
Zuclopenthixol—Tension—Doxorubicin—ovarian cancer	0.000663	0.000713	CcSEcCtD
Zuclopenthixol—Vomiting—Paclitaxel—ovarian cancer	0.000663	0.000713	CcSEcCtD
Zuclopenthixol—Malaise—Epirubicin—ovarian cancer	0.000658	0.000708	CcSEcCtD
Zuclopenthixol—Rash—Paclitaxel—ovarian cancer	0.000657	0.000707	CcSEcCtD
Zuclopenthixol—Dermatitis—Paclitaxel—ovarian cancer	0.000657	0.000706	CcSEcCtD
Zuclopenthixol—Nervousness—Doxorubicin—ovarian cancer	0.000656	0.000706	CcSEcCtD
Zuclopenthixol—Vertigo—Epirubicin—ovarian cancer	0.000656	0.000706	CcSEcCtD
Zuclopenthixol—Syncope—Epirubicin—ovarian cancer	0.000655	0.000704	CcSEcCtD
Zuclopenthixol—Leukopenia—Epirubicin—ovarian cancer	0.000653	0.000703	CcSEcCtD
Zuclopenthixol—Headache—Paclitaxel—ovarian cancer	0.000653	0.000702	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Docetaxel—ovarian cancer	0.000651	0.0007	CcSEcCtD
Zuclopenthixol—Palpitations—Epirubicin—ovarian cancer	0.000645	0.000694	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Epirubicin—ovarian cancer	0.000642	0.00069	CcSEcCtD
Zuclopenthixol—Vision blurred—Doxorubicin—ovarian cancer	0.000637	0.000685	CcSEcCtD
Zuclopenthixol—Asthenia—Docetaxel—ovarian cancer	0.000634	0.000682	CcSEcCtD
Zuclopenthixol—Convulsion—Epirubicin—ovarian cancer	0.000633	0.00068	CcSEcCtD
Zuclopenthixol—Hypertension—Epirubicin—ovarian cancer	0.00063	0.000678	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000627	0.000674	CcSEcCtD
Zuclopenthixol—Pruritus—Docetaxel—ovarian cancer	0.000625	0.000672	CcSEcCtD
Zuclopenthixol—Myalgia—Epirubicin—ovarian cancer	0.000622	0.000669	CcSEcCtD
Zuclopenthixol—Agitation—Doxorubicin—ovarian cancer	0.000621	0.000668	CcSEcCtD
Zuclopenthixol—Fluphenazine—ABCB1—ovarian cancer	0.000619	0.0732	CrCbGaD
Zuclopenthixol—Anxiety—Epirubicin—ovarian cancer	0.000619	0.000666	CcSEcCtD
Zuclopenthixol—Nausea—Paclitaxel—ovarian cancer	0.000619	0.000666	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000617	0.000664	CcSEcCtD
Zuclopenthixol—Discomfort—Epirubicin—ovarian cancer	0.000614	0.000661	CcSEcCtD
Zuclopenthixol—Malaise—Doxorubicin—ovarian cancer	0.000609	0.000655	CcSEcCtD
Zuclopenthixol—Dry mouth—Epirubicin—ovarian cancer	0.000608	0.000654	CcSEcCtD
Zuclopenthixol—Vertigo—Doxorubicin—ovarian cancer	0.000607	0.000653	CcSEcCtD
Zuclopenthixol—Syncope—Doxorubicin—ovarian cancer	0.000606	0.000652	CcSEcCtD
Zuclopenthixol—Leukopenia—Doxorubicin—ovarian cancer	0.000605	0.00065	CcSEcCtD
Zuclopenthixol—Diarrhoea—Docetaxel—ovarian cancer	0.000604	0.00065	CcSEcCtD
Zuclopenthixol—Palpitations—Doxorubicin—ovarian cancer	0.000597	0.000642	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000596	0.000641	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000594	0.000639	CcSEcCtD
Zuclopenthixol—Shock—Epirubicin—ovarian cancer	0.000586	0.000631	CcSEcCtD
Zuclopenthixol—Convulsion—Doxorubicin—ovarian cancer	0.000585	0.00063	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Epirubicin—ovarian cancer	0.000584	0.000629	CcSEcCtD
Zuclopenthixol—Dizziness—Docetaxel—ovarian cancer	0.000584	0.000628	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Epirubicin—ovarian cancer	0.000583	0.000628	CcSEcCtD
Zuclopenthixol—Hypertension—Doxorubicin—ovarian cancer	0.000583	0.000627	CcSEcCtD
Zuclopenthixol—Tachycardia—Epirubicin—ovarian cancer	0.000582	0.000626	CcSEcCtD
Zuclopenthixol—Skin disorder—Epirubicin—ovarian cancer	0.000579	0.000623	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000576	0.00062	CcSEcCtD
Zuclopenthixol—Myalgia—Doxorubicin—ovarian cancer	0.000575	0.000619	CcSEcCtD
Zuclopenthixol—Anxiety—Doxorubicin—ovarian cancer	0.000573	0.000617	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000571	0.000614	CcSEcCtD
Zuclopenthixol—Discomfort—Doxorubicin—ovarian cancer	0.000568	0.000611	CcSEcCtD
Zuclopenthixol—Anorexia—Epirubicin—ovarian cancer	0.000568	0.000611	CcSEcCtD
Zuclopenthixol—Chlorprothixene—ABCB1—ovarian cancer	0.000564	0.0666	CrCbGaD
Zuclopenthixol—Dry mouth—Doxorubicin—ovarian cancer	0.000562	0.000605	CcSEcCtD
Zuclopenthixol—Vomiting—Docetaxel—ovarian cancer	0.000562	0.000604	CcSEcCtD
Zuclopenthixol—Rash—Docetaxel—ovarian cancer	0.000557	0.000599	CcSEcCtD
Zuclopenthixol—Hypotension—Epirubicin—ovarian cancer	0.000557	0.000599	CcSEcCtD
Zuclopenthixol—Dermatitis—Docetaxel—ovarian cancer	0.000556	0.000599	CcSEcCtD
Zuclopenthixol—Headache—Docetaxel—ovarian cancer	0.000553	0.000595	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000551	0.000593	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000543	0.000584	CcSEcCtD
Zuclopenthixol—Shock—Doxorubicin—ovarian cancer	0.000542	0.000583	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000541	0.000582	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00054	0.000581	CcSEcCtD
Zuclopenthixol—Insomnia—Epirubicin—ovarian cancer	0.000539	0.00058	CcSEcCtD
Zuclopenthixol—Tachycardia—Doxorubicin—ovarian cancer	0.000538	0.000579	CcSEcCtD
Zuclopenthixol—Skin disorder—Doxorubicin—ovarian cancer	0.000535	0.000576	CcSEcCtD
Zuclopenthixol—Paraesthesia—Epirubicin—ovarian cancer	0.000535	0.000576	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000533	0.000573	CcSEcCtD
Zuclopenthixol—Dyspnoea—Epirubicin—ovarian cancer	0.000531	0.000571	CcSEcCtD
Zuclopenthixol—Somnolence—Epirubicin—ovarian cancer	0.00053	0.00057	CcSEcCtD
Zuclopenthixol—Anorexia—Doxorubicin—ovarian cancer	0.000526	0.000565	CcSEcCtD
Zuclopenthixol—Nausea—Docetaxel—ovarian cancer	0.000525	0.000564	CcSEcCtD
Zuclopenthixol—Dyspepsia—Epirubicin—ovarian cancer	0.000524	0.000564	CcSEcCtD
Zuclopenthixol—Decreased appetite—Epirubicin—ovarian cancer	0.000518	0.000557	CcSEcCtD
Zuclopenthixol—Hypotension—Doxorubicin—ovarian cancer	0.000515	0.000554	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000514	0.000553	CcSEcCtD
Zuclopenthixol—Fatigue—Epirubicin—ovarian cancer	0.000514	0.000553	CcSEcCtD
Zuclopenthixol—Pain—Epirubicin—ovarian cancer	0.00051	0.000548	CcSEcCtD
Zuclopenthixol—Constipation—Epirubicin—ovarian cancer	0.00051	0.000548	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000502	0.00054	CcSEcCtD
Zuclopenthixol—Insomnia—Doxorubicin—ovarian cancer	0.000499	0.000536	CcSEcCtD
Zuclopenthixol—Trifluoperazine—ABCB1—ovarian cancer	0.000495	0.0585	CrCbGaD
Zuclopenthixol—Paraesthesia—Doxorubicin—ovarian cancer	0.000495	0.000533	CcSEcCtD
Zuclopenthixol—Dyspnoea—Doxorubicin—ovarian cancer	0.000492	0.000529	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Epirubicin—ovarian cancer	0.000491	0.000528	CcSEcCtD
Zuclopenthixol—Somnolence—Doxorubicin—ovarian cancer	0.00049	0.000527	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000487	0.000524	CcSEcCtD
Zuclopenthixol—Dyspepsia—Doxorubicin—ovarian cancer	0.000485	0.000522	CcSEcCtD
Zuclopenthixol—Quetiapine—ABCB1—ovarian cancer	0.00048	0.0567	CrCbGaD
Zuclopenthixol—Decreased appetite—Doxorubicin—ovarian cancer	0.000479	0.000516	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000476	0.000512	CcSEcCtD
Zuclopenthixol—Fatigue—Doxorubicin—ovarian cancer	0.000475	0.000511	CcSEcCtD
Zuclopenthixol—Constipation—Doxorubicin—ovarian cancer	0.000471	0.000507	CcSEcCtD
Zuclopenthixol—Pain—Doxorubicin—ovarian cancer	0.000471	0.000507	CcSEcCtD
Zuclopenthixol—Abdominal pain—Epirubicin—ovarian cancer	0.000471	0.000507	CcSEcCtD
Zuclopenthixol—Body temperature increased—Epirubicin—ovarian cancer	0.000471	0.000507	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000454	0.000489	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000451	0.000485	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Epirubicin—ovarian cancer	0.000439	0.000472	CcSEcCtD
Zuclopenthixol—Abdominal pain—Doxorubicin—ovarian cancer	0.000436	0.000469	CcSEcCtD
Zuclopenthixol—Body temperature increased—Doxorubicin—ovarian cancer	0.000436	0.000469	CcSEcCtD
Zuclopenthixol—Asthenia—Epirubicin—ovarian cancer	0.000427	0.00046	CcSEcCtD
Zuclopenthixol—Pruritus—Epirubicin—ovarian cancer	0.000422	0.000453	CcSEcCtD
Zuclopenthixol—Clozapine—ABCB1—ovarian cancer	0.000413	0.0488	CrCbGaD
Zuclopenthixol—Diarrhoea—Epirubicin—ovarian cancer	0.000408	0.000439	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000406	0.000437	CcSEcCtD
Zuclopenthixol—Asthenia—Doxorubicin—ovarian cancer	0.000396	0.000426	CcSEcCtD
Zuclopenthixol—Dizziness—Epirubicin—ovarian cancer	0.000394	0.000424	CcSEcCtD
Zuclopenthixol—Pruritus—Doxorubicin—ovarian cancer	0.00039	0.00042	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ABCB1—ovarian cancer	0.000389	0.0459	CrCbGaD
Zuclopenthixol—Vomiting—Epirubicin—ovarian cancer	0.000379	0.000408	CcSEcCtD
Zuclopenthixol—Diarrhoea—Doxorubicin—ovarian cancer	0.000377	0.000406	CcSEcCtD
Zuclopenthixol—Rash—Epirubicin—ovarian cancer	0.000376	0.000404	CcSEcCtD
Zuclopenthixol—Dermatitis—Epirubicin—ovarian cancer	0.000375	0.000404	CcSEcCtD
Zuclopenthixol—Headache—Epirubicin—ovarian cancer	0.000373	0.000402	CcSEcCtD
Zuclopenthixol—Dizziness—Doxorubicin—ovarian cancer	0.000365	0.000392	CcSEcCtD
Zuclopenthixol—Nausea—Epirubicin—ovarian cancer	0.000354	0.000381	CcSEcCtD
Zuclopenthixol—Vomiting—Doxorubicin—ovarian cancer	0.000351	0.000377	CcSEcCtD
Zuclopenthixol—Rash—Doxorubicin—ovarian cancer	0.000348	0.000374	CcSEcCtD
Zuclopenthixol—Dermatitis—Doxorubicin—ovarian cancer	0.000347	0.000374	CcSEcCtD
Zuclopenthixol—Headache—Doxorubicin—ovarian cancer	0.000345	0.000372	CcSEcCtD
Zuclopenthixol—Nausea—Doxorubicin—ovarian cancer	0.000327	0.000352	CcSEcCtD
